APA (7th ed.) Citation

Iméne Ben Toumia, Tiziana Bachetti, Leila Chekir-Ghedira, Aldo Profumo, Marco Ponassi, Alessandro Di Domizio, . . . Camillo Rosano. (2024). Fraisinib: A calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Iméne Ben Toumia, et al. Fraisinib: A Calixpyrrole Derivative Reducing A549 Cell-derived NSCLC Tumor in Vivo Acts as a Ligand of the Glycine-tRNA Synthase, a New Molecular Target in Oncology. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Iméne Ben Toumia, et al. Fraisinib: A Calixpyrrole Derivative Reducing A549 Cell-derived NSCLC Tumor in Vivo Acts as a Ligand of the Glycine-tRNA Synthase, a New Molecular Target in Oncology. Frontiers Media S.A., 2024.